Hany Anton, MD
Nephrology · Pompano Beach, FLNPI 1164402657
Payments from drug & device makers
Across 29 payments — averaging $385.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merit Medical Systems Inc$9K
- AstraZeneca$1K
- Avenu Medical Inc.$304
- Nxstage Medical, Inc.$239
- Medtronic$227
- Vifor Pharma, Inc.$125
- plus $414 from 8 others
What the payments were for
- Consulting fees$6746%
- Travel & lodging$4864%
- Food & beverage$1,43713%
- Other$8,57177%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merit Medical Systems Inc | 1 | $8,571 |
| AstraZeneca | 8 | $1,287 |
| Avenu Medical Inc. | 6 | $304 |
| Nxstage Medical, Inc. | 2 | $239 |
| Medtronic | 2 | $227 |
| Vifor Pharma, Inc. | 1 | $125 |
| Bayer | 1 | $125 |
| Fresenius USA Marketing, Inc. | 1 | $96 |
| Bard Peripheral Vascular, Inc. | 2 | $74 |
| Mozarc Medical US LLC | 1 | $41 |
| Angiodynamics, Inc. | 1 | $28 |
| Siemens Medical Solutions USA, Inc. | 1 | $22 |
| Cardinal Health 200 LLC | 1 | $15 |
| W. L. Gore & Associates, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOKELMA$1,160
- Ellipsys$241
- ELLIPSYS VASCULAR ACCESS SYSTEM$196
- NXSTAGE SYSTEM ONE$148
- NXSTAGE PUREFLOW SOLUTION$148
- Veltassa$125
- Kerendia$125
How this compares
$11,168 in reported general payments places this provider in the 80th percentile of 756 nephrology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 19 | $32,696 |
| EliquisApixaban | 13 | $7,644 |
| Sevelamer Carbonate | 23 | $3,205 |
| Febuxostat | 14 | $2,737 |
| Nifedipine ErNifedipine | 95 | $2,630 |
| Telmisartan | 60 | $2,174 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 37 | $2,007 |
| Nebivolol Hcl | 22 | $1,628 |
| Olmesartan Medoxomil | 102 | $1,537 |
| Potassium Citrate ErPotassium Citrate | 16 | $1,321 |
| Losartan Potassium | 95 | $826 |
| Tamsulosin Hcl | 42 | $487 |
| Amlodipine Besylate | 63 | $396 |
| Torsemide | 18 | $364 |
| Metoprolol Succinate | 18 | $207 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Pompano Beach
- Thomas MarburyOrlando$41.1M
- Julio VijilHollywood$16.1M
- Steven ZeigHollywood$14.3M
- Oscar GalvezMiami$14.2M
- Jesus NavarroTampa$13.3M
- Arvind MadanOrlando$9.7M
- David HalpertAtlantis$4.2M
- Wayne KotzkerFort Lauderdale$3.4M
- Edouard MartinLauderdale Lakes$2.7M
- Jorge PosadaCoral Gables$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.